Canada markets close in 38 minutes

Aurora Cannabis Inc. (ACB.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
3.7400-0.2200 (-5.56%)
As of 03:22PM EDT. Market open.
Full screen
Previous Close3.9600
Open3.8900
Bid3.7500 x 0
Ask3.7600 x 0
Day's Range3.7100 - 3.9900
52 Week Range2.8700 - 12.8800
Volume1,157,851
Avg. Volume1,910,343
Market Cap848.221M
Beta (5Y Monthly)3.08
PE Ratio (TTM)N/A
EPS (TTM)-1.9430
Earnings DateMay 12, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.66
  • CNW Group

    Aurora Strengthens Leadership Position in Germany with EU-GMP Certification at Preeminent Local Cannabis Production Facility

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the company has received EU-GMP certification for its state-of-the-art medical cannabis production facility in Germany. As a leading manufacturer of medical cannabis worldwide, achieving EU-GMP certification of the company's first German manufacturing site marks a significant milestone in the fulfillment of an awarded tender by the German

  • Motley Fool

    These 3 Former High-Flying Stocks Can Soar Up to 439%, According to Wall Street

    No matter your level of experience investing money on Wall Street, it's been a rough year. Meanwhile, the technology-driven Nasdaq Composite declined close to 30% from its November all-time high, firmly placing it in a bear market. This is why Wall Street analysts typically have a bullish outlook on many of the companies they cover.

  • Motley Fool

    Why Aurora Cannabis, Canopy, and Sundial Stocks Popped on Friday

    Canadian cannabis company Aurora Cannabis (NASDAQ: ACB) reported its fiscal third-quarter 2022 earnings last night, and in so doing, sparked a rally across the cannabis sector today. As of 1 p.m. ET, shares of Aurora Cannabis itself are already up 13%, and peer producers Canopy Growth (NASDAQ: CGC) and Sundial Growers (NASDAQ: SNDL) are benefiting as well -- up 8.5% and 5.9%, respectively. Heading into Q3, analysts had forecast that Aurora Cannabis would lose $0.19 per share (0.25 Canadian dollars, and furthermore, this was a pro forma prediction) on sales of $41.5 million -- about CA$53.7 million.